OINDPnews


Copley Scientific banner

News

St. Renatus gets $5 million additional funding for nasal dental anesthetic

According to St. Renatus, Blue Ocean Holdings is investing an additional $5 million in the company. The funds will go toward completion of St. Renatus's New Drug Application (NDA) for its nasal mist dental anesthesia and for commercialization. St. Renatus says that it plans to submit the NDA in 2014. In February 2014, St. Renatus announced that it had completed … [Read more...] about St. Renatus gets $5 million additional funding for nasal dental anesthetic

GSK announces that Phase 3 study results show Anoro Ellipta improves lung function more than Advair Diskus

GSK and Theravance have announced that results from three phase 3 studies comparing the Anoro Ellipta umeclidinium/vilanterol DPI to Advair and Seretide Diskus in COPD patients show greater improvement in lung function for patients treated with Anoro Ellipta. The three randomized, double-blind, double-dummy, parallel group studies involved a total of about 2,100 … [Read more...] about GSK announces that Phase 3 study results show Anoro Ellipta improves lung function more than Advair Diskus

Adasuve launched in Romania

Alexza Pharmaceuticals has announced that its European partner Ferrer has launched Adasuve loxapine inhalation powder for the treatment of agitation in schizophrenic or bipolar patients in Romania. Ferrer has a distribution agreement with Galenica for distribution in that country. In the US, Teva launched the product earlier this month. Alexza President and CEO … [Read more...] about Adasuve launched in Romania

Hi-Tech Pharmacal reports large drop in nasal spray sales

According to Hi-Tech Pharmacal, sales of its fluticasone propionate nasal spray dropped from $23 million in the 3rd quarter of the 2013 fiscal year to only $10.9 million for the same period in 2014. The decrease was a combination of lower unit sales and a lower average price, the company said. Sales of a homeopathic OTC nasal spray called Sinus Buster marketed by … [Read more...] about Hi-Tech Pharmacal reports large drop in nasal spray sales

Gerresheimer expands US inhaler manufacturing capacity

Device manufacturer Gerresheimer has announced that it is adding 60,000 sq ft to its production facility in Peachtree City, GA in order to accommodate increased demand for inhalers and other plastic medical devices. Approximately 40,000 sq ft of the expansion will be devoted to ISO class 8 clean room space. The company says that it will spend "double digit million … [Read more...] about Gerresheimer expands US inhaler manufacturing capacity

Verona looking to raise up to £14 million for development of inhaled drugs

Verona Pharma has announced that it is looking to raise up to £14 million through a placing, subscription, and open offer of more than 630 million new ordinary shares, conditioned on approval of shareholders. A general meeting will be held on March 24 2014. According to the company, the proceeds would be used for development of its inhaled dual phosphodiesterase (PDE) … [Read more...] about Verona looking to raise up to £14 million for development of inhaled drugs

Teva launches Adasuve in US

Teva has announced the US launch of Adasuve loxapine inhalation powder for the treatment of agitation in schizophrenic or bipolar patients. The company licensed Adasuve from its developer, Alexza Pharmaceuticals in May 2013. Alexza's Staccato thermal aerosol inhaler is the delivery device. Teva Select Brands and Teva Women’s Health VP and General Manager Michael … [Read more...] about Teva launches Adasuve in US